About us
Science
Pipeline
Strategy
News
Investor Relations
Overview
About Captor
Strategy
Sustainability
Management
Management Board
Supervisory Board
General Meetings
Corporate Documents and Governance
Corporate Documents
FAQ
Shares and Related Information
Shares
Stock Price
Shareholders
Capital Market Institutions
Reports
Current
Periodic
Finance
Selected Financial Data
Dividend Policy
Incentive Scheme
Covering Analysts
Investor Resources and Calendar
Presentations & Posters
Calendar
Media Kit
Contact
Careers
Contact
PL
|
EN
About us
Science
Pipeline
Strategy
News
Investor Relations
OVERVIEW
About Captor
Strategy
Sustainability
MANAGEMENT
Management Board
Supervisory Board
GENERAL MEETINGS
CORPORATE DOCUMENTS AND GOVERNANCE
Corporate Documents
FAQ
SHARES AND RELATED INFORMATION
Shares
Stock Price
Shareholders
Capital Market Institutions
REPORTS
Current
Periodic
FINANCE
Selected Financial Data
Dividend Policy
Incentive Scheme
Covering Analysts
INVESTOR RESOURCES AND CALENDAR
Presentations & Posters
Calendar
Media Kit
CONTACT
Careers
Contact
PL
|
EN
Home
"Assessment of mutagenic potential by the Ames test"
Captor Therapeutics ®
News
"Assessment of mutagenic potential by the Ames test"
30.11.-0001
Share:
